{
  "drug_name": "Clocortolone",
  "generic_name": [
    "CLOCORTOLONE PIVALATE"
  ],
  "brand_names": [
    "Clocortolone Pivalate"
  ],
  "drug_interactions": [],
  "warnings": [],
  "adverse_reactions": [
    "ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning Itching Irritation Dryness Folliculitis Hypertrichosis Acneform eruptions Hypopigmentation Perioral dermatitis Allergic contact dermatitis Maceration of the skin Secondary infection Skin atrophy Striae Miliaria"
  ],
  "contraindications": [
    "CONTRAINDICATIONS Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation."
  ],
  "dosage_administration": [
    "DOSAGE AND ADMINISTRATION Apply clocortolone pivalate cream USP, 0.1% sparingly to the affected areas three times a day and rub in gently. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate anti-microbial therapy instituted."
  ],
  "indications": [
    "INDICATIONS AND USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses."
  ],
  "fetched_at": "2025-09-30T22:09:45.427703",
  "source": "OpenFDA"
}